Citius Pharmaceuticals Inc
USD0.14
-0.01 (-3.93%)
IPO Date
2017-08-03
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.68
Prev. Close
$0.15
Day Low
$0.02
Day High
$0.15
52W Low
$0.02
52W High
$0.15
Volume
0.01M
| 10,000 |
| $3.45 |
| 19 Sept 2017 | Dutia Suren G | director | A-Award | Acquired | 10,000 | $3.45 |
| 19 Sept 2017 | Mazur Leonard L | director, 10 percent owner, officer: Executive Chairman | A-Award | Acquired | 40,000 | $3.45 |
| 19 Sept 2017 | HOLUBIAK MYRON Z | director, officer: President and CEO | A-Award | Acquired | 40,000 | $3.45 |
| 19 Sept 2017 | SAFIR HOWARD | director | A-Award | Acquired | 10,000 | $3.45 |
| 19 Sept 2017 | Webb Carol | director | A-Award | Acquired | 10,000 | $3.45 |
| 28 Aug 2017 | Mazur Leonard L | director, 10 percent owner, officer: Executive Chairman | P-Purchase | Acquired | 11,000 | $2.68 |
| 28 Aug 2017 | Mazur Leonard L | director, 10 percent owner, officer: Executive Chairman | P-Purchase | Acquired | 11,000 | $4.13 |
| 10 Aug 2017 | Mazur Leonard L | director, 10 percent owner, officer: Executive Chairman | C-Conversion | Acquired | 1,547,067 | $3.09 |